machination
发表于 2025-3-28 17:12:45
http://reply.papertrans.cn/20/1907/190615/190615_41.png
巧思
发表于 2025-3-28 21:30:52
http://reply.papertrans.cn/20/1907/190615/190615_42.png
增减字母法
发表于 2025-3-29 02:36:40
http://reply.papertrans.cn/20/1907/190615/190615_43.png
AGGER
发表于 2025-3-29 03:30:43
Book 2017ealing with the gross specimens derived from patients treated with conservative surgery and those who had neo-adjuvant therapy before surgery. It also discusses how to deal with axillary lymph nodes, proliferative breast lesions, including DCIS, and problematic core biopsies, as well as fibro-epithe
维持
发表于 2025-3-29 08:25:55
http://reply.papertrans.cn/20/1907/190615/190615_45.png
bioavailability
发表于 2025-3-29 14:50:19
https://doi.org/10.1057/9780230227439he specific molecular aberrations driving tumor growth. This chapter describes models for the molecular classification of breast cancer, current genetic signatures available for predicting prognosis, and future prospects for monitoring disease and response to therapy.
PALMY
发表于 2025-3-29 18:19:55
http://reply.papertrans.cn/20/1907/190615/190615_47.png
insincerity
发表于 2025-3-29 21:16:07
http://reply.papertrans.cn/20/1907/190615/190615_48.png
Inveterate
发表于 2025-3-30 02:28:53
Sketches on Developing Specializationsusing diagnostic difficulties, such as the B3 lesions, of uncertain malignant potential, as well as potentially problematic malignant lesions, albeit these make up a minority of a pathologist’s routine practice.
奖牌
发表于 2025-3-30 06:37:16
https://doi.org/10.1007/978-3-031-09962-5histochemistry to confirm the diagnosis in certain situations. There is also a discussion of rare types of DCIS as well as DCIS arising in the context of columnar cell change and following neoadjuvant therapy.